Please see below all current gynaecological cancer clinical trials of the Central Coast Cancer Centre.
Name: ICON 9
An international phase III randomised study to evaluate the efficacy of maintenance therapy with olaparib and cediranib or olapartib alone in patients with relapsed platinum sensitive-ovarian cancer following a response to platinum-based chemotherapy.
Principal Investigator: Dr Craig Kukard
Study Coordinator: Michelle Dixon
Status: Closed
Condition: Ovarian Cancer
More information about ICON 9
Name: AtTEND
Phase III Double Blind Randomized Placebo Controlled Trial of Atezolizumab in Combination with Paclitaxel and Carboplatin in Women with Advanced/Recurrent Endometrial Cancer
Principal Investigator: Dr Susan Tiley
Study Coordinator: Bronwyn Raymond
Status: Closed
Condition: Ovarian Cancer
More information about AtTEND
Name: SOLACE II
A phase II randomised trial comparing immune priming by low dose oral cyclophosphamide plus olaparib versus priming by olaparib alone, prior to combination therapy with olaparib plus durvalumab, versus single agent olaparib alone, in asymptomatic platinum-sensitive recurrent ovarian, fallopian tube or primary peritoneal cancers with homologous recombination repair defects.
Principal Investigator: Dr Susan Tiley
Study Coordinator: Michelle Dixon
Status: Recruiting
Condition: Ovarian Cancer
More information about SOLACE
More information
For more information about medical oncology clinical trials please contact the Nurse Unit Manager on 02 4320 9890 or see:
Research and Clinical Trials